Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Ocular Therapeutix Stock Price, Quotes and Forecasts | NASDAQ:OCUL | Benzinga

Q: What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Ocular Therapeutix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCUL.

Open	$6.36
Close	$7.11
Volume / Avg.	1.59M / 1.41M
Day Range	$6.21 - $7.20
52 Wk Range	4.06 - 11.78
Market Cap	$1.09B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	8.04%
Days to Cover	7.71

Recent News

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside

Needham starts coverage on Ocular Therapeutix with a Buy rating, citing Axpaxli's potential in wet AMD and forecasting $1.5 billion peak sales.

Vandana Singh

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.36
Close	$7.11
Volume / Avg.	1.59M / 1.41M
Day Range	$6.21 - $7.20
52 Wk Range	4.06 - 11.78
Market Cap	$1.09B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	8.04%
Days to Cover	7.71

About Ocular Therapeutix Inc

Sector

Health Care

Industry

Pharmaceuticals

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and con...

Got Questions? Ask

How has OCUL's EPS changed?

How is OCUL's revenue growing?

What is OCUL's gross margin?

What is OCUL's net income trend?

What is OCUL's Sharpe ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ocular Therapeutix (OCUL) stock?

You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.

View our list of the best stock brokerages

Who are Ocular Therapeutix (OCUL) competitors?

Other companies in Ocular Therapeutix’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS) and Phibro Animal Health (NASDAQ:PAHC).

What is the forecast, or price target, for Ocular Therapeutix (OCUL) stock?

Ocular Therapeutix has a consensus price target of $16.42.

What is the current price for Ocular Therapeutix (OCUL)?

The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $6.95 last updated April 11, 2025 at 5:53 PM EDT.

Does Ocular Therapeutix (OCUL) pay a dividend?

There are no upcoming dividends for Ocular Therapeutix.

When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?

Ocular Therapeutix’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Ocular Therapeutix (OCUL) going to split?

There is no upcoming split for Ocular Therapeutix.

What sector and industry does Ocular Therapeutix (OCUL) operate in?

Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Ocular Therapeutix Stock Price, Quotes and Forecasts

Ocular Therapeutix (OCUL) Forecast